2017年4月23日日曜日
Pitavastatin Pleiotropic Study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387666/
Conclusions
Pitavastatin not only improved atherosis measured by IMT and the sclerosis measured by cIBS values, but also attenuated inflammation of plaques at the same site as measured by max SUV. The present study indicated that pitavastatin had a stronger effect on regression and stabilization of plaques in the thoracic aorta compared with a mild hydrophilic statin.Acknowledgements
This study was funded by a grant from Japan vascular disease research foundation, Kyoto, Japan.
2017年4月19日水曜日
Simple Radical Metabolic Pathways for Anti-TB Drug & Others
Radical Metabolic Pathways
For Isoniazid, Delamanid and Epalrestat.
This Paper deals with the new radical metabolic patway
for two ant-TB drugs (Isoniazid and Delamanid) and one
ARI (aldose reductase inhibitor).
http://www.pnas.org/content/100/24/13881.full
Pitavastatin Works As RhoA
Inverse Agonist But Not GPCR120 Ligand.
登録:
投稿 (Atom)